REGION NORDJYLLAND has a total of 12 patent applications. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology, measurement and biotechnology are TORSANA DIABETES DIAGNOSTICS A, BIOTECHPLEX CORP and VIA MEDICAL CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Computer technology | |
#5 | Pharmaceuticals | |
#6 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Handberg Aase | 5 |
#2 | Jensen Svend Eggert | 4 |
#3 | Hansen Steen Møller | 3 |
#4 | Skjelland Mona | 2 |
#5 | Larsen Torben Bjerregaard | 2 |
#6 | Hejlesen Ole Kristian | 2 |
#7 | Halvorsen Bente | 2 |
#8 | Lundbye-Christensen Søren | 1 |
#9 | Lundbye-Christensen Soeren | 1 |
#10 | Thorgaard Per | 1 |
Publication | Filing date | Title |
---|---|---|
US2016370365A1 | Method of evaluation of the relative risk of developing atherosclerosis in patients | |
WO2015162255A1 | Apparatus and method for delivering a gas mixture to a child | |
EP2881057A1 | Apparatus for creating linear lesions in body tissue within a body vessel | |
US2013149386A1 | Cd36 as biomarker for steatosis | |
WO2012079576A1 | Methods and models for predicting dosage of a drug and/or response in an individual | |
EP1754058A2 | Method for determining the amount of circulating CD36 |